Works matching IS 14620324 AND DT 2023 AND VI 62 AND IP 2
Results: 62
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. e18, doi. 10.1093/rheumatology/keac456
- By:
- Publication type:
- Article
Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 497, doi. 10.1093/rheumatology/keac417
- By:
- Publication type:
- Article
Correction to: Healthcare utilization and economic burden in systemic sclerosis: a systematic review.
- Published in:
- 2023
- Publication type:
- Correction Notice
Macrophages as determinants and regulators of fibrosis in systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 535, doi. 10.1093/rheumatology/keac410
- By:
- Publication type:
- Article
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 835, doi. 10.1093/rheumatology/keac427
- By:
- Publication type:
- Article
Point-of-care ultrasonography in large vessel involvement by IgG4-related disease: an opportunity for monitoring?
- Published in:
- 2023
- By:
- Publication type:
- Case Study
'What is fuelling the immune response in systemic lupus erythematosus?' Evaluating the key metabolites driving plasmablast differentiation.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Clinical and therapeutic diversity in adult chronic nonbacterial osteomyelitis (CNO) of the sternocostoclavicular region: a meta-analysis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 512, doi. 10.1093/rheumatology/keac443
- By:
- Publication type:
- Article
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud's.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 824, doi. 10.1093/rheumatology/keac426
- By:
- Publication type:
- Article
Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 523, doi. 10.1093/rheumatology/keac409
- By:
- Publication type:
- Article
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 747, doi. 10.1093/rheumatology/keac402
- By:
- Publication type:
- Article
COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 829, doi. 10.1093/rheumatology/keac400
- By:
- Publication type:
- Article
Adverse events of treatment with rituximab in patients with myositis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. e16, doi. 10.1093/rheumatology/keac398
- By:
- Publication type:
- Article
Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 596, doi. 10.1093/rheumatology/keac397
- By:
- Publication type:
- Article
Management of carpal tunnel syndrome in primary care.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 495, doi. 10.1093/rheumatology/keac396
- By:
- Publication type:
- Article
Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus–associated refractory cerebral vasculitis induces immune tolerance.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Rheumatology research in the post-COVID era—challenges and solutions.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Work situation, work ability and expectation of returning to work in patients with systemic autoimmune myopathies.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 785, doi. 10.1093/rheumatology/keac389
- By:
- Publication type:
- Article
Correction to: Editor's Acknowledgement.
- Published in:
- 2023
- Publication type:
- Correction Notice
Long-term cardiovascular outcomes and temporal trends in patients diagnosed with ANCA-associated vasculitis: a Danish nationwide registry study.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 735, doi. 10.1093/rheumatology/keac386
- By:
- Publication type:
- Article
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 872, doi. 10.1093/rheumatology/keac385
- By:
- Publication type:
- Article
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 984, doi. 10.1093/rheumatology/keac384
- By:
- Publication type:
- Article
Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 861, doi. 10.1093/rheumatology/keac381
- By:
- Publication type:
- Article
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 606, doi. 10.1093/rheumatology/keac375
- By:
- Publication type:
- Article
Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 775, doi. 10.1093/rheumatology/keac374
- By:
- Publication type:
- Article
Genetic contributions to female gout and hyperuricaemia using genome-wide association study and polygenic risk score analyses.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 638, doi. 10.1093/rheumatology/keac369
- By:
- Publication type:
- Article
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 726, doi. 10.1093/rheumatology/keac365
- By:
- Publication type:
- Article
Upregulated expression of FFAR2 and SOC3 genes is associated with gout.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 977, doi. 10.1093/rheumatology/keac360
- By:
- Publication type:
- Article
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 647, doi. 10.1093/rheumatology/keac358
- By:
- Publication type:
- Article
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 583, doi. 10.1093/rheumatology/keac357
- By:
- Publication type:
- Article
Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 841, doi. 10.1093/rheumatology/keac346
- By:
- Publication type:
- Article
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 617, doi. 10.1093/rheumatology/keac353
- By:
- Publication type:
- Article
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 766, doi. 10.1093/rheumatology/keac351
- By:
- Publication type:
- Article
Comment on: Distal coronary artery abnormalities in Kawasaki disease: experience on CT coronary angiography in 176 children: reply.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Comment on: Distal coronary artery abnormalities in Kawasaki disease: experience on CT coronary angiography in 176 children.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
The role of YAP1 target gene CTGF in the anoikis resistance of rheumatoid arthritis synovial fibroblasts.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 850, doi. 10.1093/rheumatology/keac354
- By:
- Publication type:
- Article
Circulating and renal fibrocytes are associated with interstitial fibrosis in lupus nephritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 914, doi. 10.1093/rheumatology/keac345
- By:
- Publication type:
- Article
Resting state functional connectivity in SLE patients and association with cognitive impairment and blood–brain barrier permeability.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 685, doi. 10.1093/rheumatology/keac343
- By:
- Publication type:
- Article
Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 629, doi. 10.1093/rheumatology/keac342
- By:
- Publication type:
- Article
Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 716, doi. 10.1093/rheumatology/keac339
- By:
- Publication type:
- Article
Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 905, doi. 10.1093/rheumatology/keac338
- By:
- Publication type:
- Article
Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 958, doi. 10.1093/rheumatology/keac337
- By:
- Publication type:
- Article
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 804, doi. 10.1093/rheumatology/keac335
- By:
- Publication type:
- Article
Cancer occurrence after SLE: effects of medication-related factors, disease-related factors and survival from an observational study.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 659, doi. 10.1093/rheumatology/keac316
- By:
- Publication type:
- Article
Trajectories of depressive symptoms in systemic lupus erythematosus over time.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 676, doi. 10.1093/rheumatology/keac333
- By:
- Publication type:
- Article
Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 924, doi. 10.1093/rheumatology/keac327
- By:
- Publication type:
- Article
DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 934, doi. 10.1093/rheumatology/keac324
- By:
- Publication type:
- Article
Development and psychometric evaluation of the PMR-Impact Scale: a new patient reported outcome measure for polymyalgia rheumatica.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 758, doi. 10.1093/rheumatology/keac317
- By:
- Publication type:
- Article
The BILAG-2004 index is associated with development of new damage in SLE.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 668, doi. 10.1093/rheumatology/keac334
- By:
- Publication type:
- Article